Nimble & Svar Life Science Announce Collaboration to Discover, Develop and Commercialize Diagnostic Tests based on Nimble’s Novel Biomarker Discovery Engine April 16, 2020 READ MORE
High-Throughput Identification of MHC Class I Binding Peptides Using an Ultradense Peptide Array. March 15, 2020 READ MORE
Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination. March 3, 2020 READ MORE
Nimble Announces Collaboration with Genentech to Discover and Develop Novel Peptide-Based Therapeutics February 19, 2020 READ MORE
Dr. Jigar Patel, CEO of Nimble Therapeutics, speaks at BIO-Europe® 2019 in Hamburg December 4, 2019 READ MORE
